224 related articles for article (PubMed ID: 33077700)
1. Sex-Biased Molecular Signature for Overall Survival of Liver Cancer Patients.
Kim SY; Song HK; Lee SK; Kim SG; Woo HG; Yang J; Noh HJ; Kim YS; Moon A
Biomol Ther (Seoul); 2020 Nov; 28(6):491-502. PubMed ID: 33077700
[TBL] [Abstract][Full Text] [Related]
2. Molecular Markers in Sex Differences in Cancer.
Shin JY; Jung HJ; Moon A
Toxicol Res; 2019 Oct; 35(4):331-341. PubMed ID: 31636844
[TBL] [Abstract][Full Text] [Related]
3. Sex-biased differences in the correlation between epithelial-to-mesenchymal transition-associated genes in cancer cell lines.
Kim SY; Lee S; Lee E; Lim H; Shin JY; Jung J; Kim SG; Moon A
Oncol Lett; 2019 Dec; 18(6):6852-6868. PubMed ID: 31807189
[TBL] [Abstract][Full Text] [Related]
4. Gender medicine: a task for the third millennium.
Baggio G; Corsini A; Floreani A; Giannini S; Zagonel V
Clin Chem Lab Med; 2013 Apr; 51(4):713-27. PubMed ID: 23515103
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
6. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes.
Dobruch J; Daneshmand S; Fisch M; Lotan Y; Noon AP; Resnick MJ; Shariat SF; Zlotta AR; Boorjian SA
Eur Urol; 2016 Feb; 69(2):300-10. PubMed ID: 26346676
[TBL] [Abstract][Full Text] [Related]
7. Sex Differences in Cancer: Epidemiology, Genetics and Therapy.
Kim HI; Lim H; Moon A
Biomol Ther (Seoul); 2018 Jul; 26(4):335-342. PubMed ID: 29949843
[TBL] [Abstract][Full Text] [Related]
8. [Gender-specific influencing factors on incidence, risk factors and outcome of carcinoma of the liver, gallbladder, extrahepatic bile duct and pancreas].
Grundmann RT; Meyer F
Zentralbl Chir; 2014 Apr; 139(2):184-92. PubMed ID: 24777600
[TBL] [Abstract][Full Text] [Related]
9. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK.
White A; Ironmonger L; Steele RJC; Ormiston-Smith N; Crawford C; Seims A
BMC Cancer; 2018 Sep; 18(1):906. PubMed ID: 30236083
[TBL] [Abstract][Full Text] [Related]
10. Large Scale Gene Expression Meta-Analysis Reveals Tissue-Specific, Sex-Biased Gene Expression in Humans.
Mayne BT; Bianco-Miotto T; Buckberry S; Breen J; Clifton V; Shoubridge C; Roberts CT
Front Genet; 2016; 7():183. PubMed ID: 27790248
[TBL] [Abstract][Full Text] [Related]
11. Sex Differences in Cancer Driver Genes and Biomarkers.
Li CH; Haider S; Shiah YJ; Thai K; Boutros PC
Cancer Res; 2018 Oct; 78(19):5527-5537. PubMed ID: 30275052
[TBL] [Abstract][Full Text] [Related]
12. A novel signature derived from immunoregulatory and hypoxia genes predicts prognosis in liver and five other cancers.
Chang WH; Forde D; Lai AG
J Transl Med; 2019 Jan; 17(1):14. PubMed ID: 30626396
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data.
Li Y; Kang K; Krahn JM; Croutwater N; Lee K; Umbach DM; Li L
BMC Genomics; 2017 Jul; 18(1):508. PubMed ID: 28673244
[TBL] [Abstract][Full Text] [Related]
14. A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction.
Wang Z; Teng D; Li Y; Hu Z; Liu L; Zheng H
Life Sci; 2018 Jun; 203():83-91. PubMed ID: 29678742
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Prognostic Signature Associated With DNA Repair Genes in Ovarian Cancer.
Sun H; Cao D; Ma X; Yang J; Peng P; Yu M; Zhou H; Zhang Y; Li L; Huo X; Shen K
Front Genet; 2019; 10():839. PubMed ID: 31572446
[No Abstract] [Full Text] [Related]
16. Establishment of a 12-gene expression signature to predict colon cancer prognosis.
Sun D; Chen J; Liu L; Zhao G; Dong P; Wu B; Wang J; Dong L
PeerJ; 2018; 6():e4942. PubMed ID: 29915691
[TBL] [Abstract][Full Text] [Related]
17. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
[TBL] [Abstract][Full Text] [Related]
18. A seven-gene signature predicts overall survival of patients with colorectal cancer.
Chen H; Sun X; Ge W; Qian Y; Bai R; Zheng S
Oncotarget; 2017 Nov; 8(56):95054-95065. PubMed ID: 29221110
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional landscape of DNA repair genes underpins a pan-cancer prognostic signature associated with cell cycle dysregulation and tumor hypoxia.
Chang WH; Lai AG
DNA Repair (Amst); 2019 Jun; 78():142-153. PubMed ID: 31054516
[TBL] [Abstract][Full Text] [Related]
20. A
Ge YZ; Xu LW; Zhou CC; Lu TZ; Yao WT; Wu R; Zhao YC; Xu X; Hu ZK; Wang M; Yang XB; Zhou LH; Zhong B; Xu Z; Li WC; Zhu JG; Jia RP
J Cancer; 2017; 8(13):2643-2652. PubMed ID: 28900502
[No Abstract] [Full Text] [Related]
[Next] [New Search]
